- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 499/87 - Compounds being unsubstituted in position 3 or with substituents other than only two methyl radicals attached in position 3, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
Patent holdings for IPC class C07D 499/87
Total number of patents in this class: 15
10-year publication summary
|
1
|
2
|
1
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allecra Therapeutics SAS | 4 |
4 |
| Fedora Pharmaceuticals Inc. | 16 |
1 |
| Orchid Chemicals & Pharmaceuticals Limited | 32 |
1 |
| Orchid Pharma Limited | 9 |
1 |
| Qilu Pharmaceutical Co., Ltd. | 114 |
1 |
| Wockhardt Limited | 194 |
1 |
| Tennor Therapeutics (Suzhou) Limited | 30 |
1 |
| Hangzhou Senze Pharmaceutical Technology Co., Ltd. | 3 |
1 |
| Shanghai Dude Medical Technology Co., Ltd | 6 |
1 |
| Zhejiang Whiteson Pharmaceutical Co., Ltd. | 2 |
1 |
| Orchid Pharma Limited | 1 |
1 |
| Orchid Pharma Limited | 1 |
1 |
| Other owners | 0 |